Related Experiment Video
Updated: Aug 3, 2025

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
Gastrointestinal Talaromyces marneffei infection in a man with AIDS: A case report
Renping Peng1, Zhipeng Peng2, Minhong Mou3
1Department of Endoscopy, The Fourth People's Hospital of Nanning, Nanning, China.
Rationale:
Reports of intestinal Talaromyces marneffei infection have increased year by year, but those of gastric infection remain rare. Here, we report disseminated talaromycosis with gastric and intestinal ulcers in an AIDS patient who was treated by antifungal agents and a proton pump inhibitor and achieved a satisfactory outcome.
Patient Concerns:
A 49-year-old man developed a gastrointestinal illness with main abdominal distension, poor appetite and a positive HIV infection to our AIDS clinical treatment center.
Diagnoses:
Electronic gastrointestinal endoscopy showed that the patient had multiple ulcers in the gastric angle, gastric antrum and large intestine. Gastric Helicobacter pylori infection was ruled out by paraulcerative histopathological analysis and a C14 urea breath test. The diagnosis was confirmed by gastroenteroscopic biopsy and metagenomic next-generation sequencing of gastric ulcer tissue.
Interventions:
Symptomatic and supportive treatments [a proton pump inhibitor and gastrointestinal motility promotion] were initiated. The patient was prescribed sequential antifungal therapy with amphotericin B (0.5 mg/kg·d, 2 weeks) and itraconazole (200 mg, q12h, 10 weeks), and then followed with itraconazole for long-term secondary prevention (200 mg, qd).
Outcomes:
The combined use of antifungal agents and a proton pump inhibitor improved the patient's condition, and he was discharged home 20 days later. He had no gastrointestinal symptom during 1 year of telephone-based follow-up.
Lessons:
In endemic areas, clinicians should be alert to the possibility of Talaromyces marneffei infection presenting with gastric ulcers in patients with AIDS, after excluding Helicobacter pylori infection.
Insights
Talaromyces marneffei infection, though rare in the stomach, can cause gastric ulcers in AIDS patients. Early diagnosis and combined antifungal and proton pump inhibitor treatment led to a successful outcome in this case.
Area of Science:
- Medical Mycology
- Gastroenterology
- Infectious Diseases
Background:
- Gastric Talaromyces marneffei infection is uncommon, with most reported cases involving the intestines.
- Disseminated talaromycosis presents a diagnostic challenge, particularly when affecting the gastrointestinal tract.
Observation:
- A 49-year-old male with HIV presented with gastrointestinal symptoms including abdominal distension and poor appetite.
- Endoscopy revealed multiple gastric and intestinal ulcers; Helicobacter pylori infection was excluded.
- Metagenomic next-generation sequencing confirmed Talaromyces marneffei in gastric ulcer tissue.
Findings:
- The patient received sequential antifungal therapy (amphotericin B followed by itraconazole) and a proton pump inhibitor.
- Combined treatment resulted in significant clinical improvement, with resolution of gastrointestinal symptoms.
- The patient remained symptom-free during a 1-year follow-up period.
Implications:
- Clinicians in endemic regions should consider Talaromyces marneffei infection in AIDS patients with unexplained gastric ulcers.
- Prompt diagnosis and appropriate antifungal treatment are crucial for managing disseminated talaromycosis.
- This case highlights the importance of advanced diagnostic techniques like metagenomic sequencing for rare fungal infections.
Related Concept Videos
Fungal Phylum Microsporidia
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

